U.K. Drug Companies Fear Impact of ‘No Deal’ Brexit

November 6, 2018

The U.K. risks losing its attraction as a location for multinational drug companies if it leaves the European Union without an agreement that can guarantee the continuing smooth trade of medicines and medical devices, health industry representatives told a parliamentary committee on Oct. 31.